John Osborne

At Good Growth, John leads the Fintech investments and leads sourcing in the US Southeast, predominantly in South Carolina and North Carolina’s Research Triangle. John is critical in assessing deal terms across all Good Growth’s investments as well as helping startups determine the right financial strategy. He is a Board member on GGC’s portfolio companies Bone Health and a Board Observer on portfolio company Lindy BioSciences.